Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
188.44
-5.51 (-2.84%)
At close: Oct 13, 2026, 4:00 PM EDT
184.00
-4.44 (-2.36%)
After-hours: Oct 13, 2026, 5:16 PM EDT
Revolution Medicines Employees
Revolution Medicines had 883 employees as of December 31, 2025. The number of employees increased by 349 or 65.36% compared to the previous year. That makes Revolution Medicines the 15,784th largest employer in the world and 2,282nd in the United States.
Employees
883
Change (1Y)
349
Growth (1Y)
65.36%
Revenue / Employee
n/a
Profits / Employee
-$2,002,588
Market Cap
40.39B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 883 | 349 | 65.36% |
| Dec 31, 2024 | 534 | 156 | 41.27% |
| Dec 31, 2023 | 378 | 132 | 53.66% |
| Dec 31, 2022 | 246 | 58 | 30.85% |
| Dec 31, 2021 | 188 | 63 | 50.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Regeneron Pharmaceuticals | 15,410 |
| BeOne Medicines AG | 12,000 |
| BioNTech SE | 7,807 |
| Moderna | 4,700 |
| Genmab | 3,119 |
| Incyte | 2,844 |
| Alnylam Pharmaceuticals | 2,500 |
| argenx SE | 1,863 |
RVMD News
- 4 days ago - Revolution Medicines price target lowered to $264 from $265 at BofA - TheFly
- 5 days ago - RBC would be buyers of Revolution Medicines after FDA docs ‘overreaction’ - TheFly
- 5 days ago - Revolution Medicines selloff ‘overdone and misguided,’ says TD Cowen - TheFly
- 5 days ago - Revolution selloff on FDA review docs should be bought, says Truist - TheFly
- 5 days ago - Revolution trading down after daraxonrasib review docs, says Stifel - TheFly
- 5 days ago - Revolution Medicines price target raised to $259 from $251 at RBC Capital - TheFly
- 6 days ago - Propanc highlights preclinical data for PRP in pancreatic ductal adenocarcinoma - TheFly
- 6 days ago - Revolution Medicines price target raised to $240 from $239 at Truist - TheFly